These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 7912363

  • 1. Ciprofibrate and lipid profile.
    Chandler HA, Batchelor AJ.
    Lancet; 1994 Jul 09; 344(8915):128-9. PubMed ID: 7912363
    [No Abstract] [Full Text] [Related]

  • 2. Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism.
    Liberopoulos E, Miltiadous G, Elisaf M.
    Diabetes Obes Metab; 2001 Apr 09; 3(2):97-8. PubMed ID: 11298731
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Implications of 4S evidence on baseline lipid levels.
    Durrington PN.
    Lancet; 1995 Jul 15; 346(8968):181. PubMed ID: 7661979
    [No Abstract] [Full Text] [Related]

  • 8. The atherogenic role of triglycerides and small, dense low density lipoproteins: impact of ciprofibrate therapy.
    Chapman MJ, Bruckert E.
    Atherosclerosis; 1996 Jul 15; 124 Suppl():S21-8. PubMed ID: 8831912
    [Abstract] [Full Text] [Related]

  • 9. Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects.
    Hernández-Mijares A, Lluch I, Vizcarra E, Martínez-Triguero ML, Ascaso JF, Carmena R.
    Nutr Metab Cardiovasc Dis; 2000 Feb 15; 10(1):1-6. PubMed ID: 10812581
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ciprofibrate and lipid profile.
    McLeod AJ, Warren RJ, Armitage M.
    Lancet; 1994 Oct 01; 344(8927):955. PubMed ID: 7934365
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of etofibrate on LDL-subtype distribution in patients with diabetic dyslipoproteinemia.
    Geiss HC, Dietlein M, Parhofer KG.
    Exp Clin Endocrinol Diabetes; 2003 Sep 01; 111(6):322-4. PubMed ID: 14520596
    [Abstract] [Full Text] [Related]

  • 20. [The action of a fibric acid derivative on lipid metabolism].
    Filip M, Păduraru I, Nechifor M, Dănilă GH, Popovici I, Filip FM, Poşircă F.
    Rev Med Chir Soc Med Nat Iasi; 1989 Sep 01; 93(3):573-6. PubMed ID: 2636755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.